Patients with diabetes should monitor blood glucose more closely during titration, since GLP-1 medications can amplify hypoglycemia risk when combined with insulin or sulfonylurea therapy
Clinical trials of brand-name tirzepatide showed up to 22.5% weight loss vs 15% with brand-name semaglutide
10.3348/kjr.2021.0112 56 PorcariS.BenechN.Valles-ColomerM.SegataN.GasbarriniA.CammarotaG.et al (2023)
With advanced diagnostic testing we uncover the underlying reasons behind weight gainhormonal imbalances, inflammation, poor sleep, stress, gut dysfunction, and metabolic slowdowns
By mimicking this hormone, Semaglutide helps individuals feel full faster and stay satisfied longer, ultimately leading to reduced calorie intake
However, as with any medication, individual responses can vary, and patients should remain vigilant for any unusual skin reactions